NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Taiwan Semiconductor
TSM
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
EWTX Edgewise Therapeutics
- 24.500
- -1.030-4.03%
Close Mar 4 16:00 ET
- 25.400
- +0.900+3.67%
Pre 04:24 ET
2.33BMarket Cap-16.90P/E (TTM)
25.860High24.220Low900.08KVolume25.120Open25.530Pre Close22.30MTurnover1.64%Turnover RatioLossP/E (Static)95.21MShares38.12052wk High5.08P/B1.34BFloat Cap14.90052wk Low--Dividend TTM54.85MShs Float40.490Historical High--Div YieldTTM6.42%Amplitude5.120Historical Low24.776Avg Price1Lot Size
Edgewise Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 38.89%158.83M | 34.49%45.54M | 37.28%40.43M | 50.39%38.11M | 35.20%34.75M | 59.59%114.36M | 53.37%33.86M | 61.27%29.45M | 53.65%25.34M | 73.37%25.7M |
| Selling and administrative expenses | 35.88%31.87M | 48.43%9.17M | 44.90%8.21M | 28.49%7.43M | 21.12%7.06M | 33.05%23.45M | 13.01%6.18M | 29.72%5.67M | 41.35%5.78M | 57.43%5.83M |
| -General and administrative expense | 35.88%31.87M | 48.43%9.17M | 44.90%8.21M | 28.49%7.43M | 21.12%7.06M | 33.05%23.45M | 13.01%6.18M | 29.72%5.67M | 41.35%5.78M | 57.43%5.83M |
| Research and development costs | 39.67%126.97M | 31.38%36.37M | 35.47%32.22M | 56.86%30.68M | 39.33%27.69M | 68.24%90.91M | 66.65%27.68M | 71.20%23.79M | 57.71%19.56M | 78.68%19.88M |
| Operating profit | -38.89%-158.83M | -34.49%-45.54M | -37.28%-40.43M | -50.39%-38.11M | -35.20%-34.75M | -59.59%-114.36M | -53.37%-33.86M | -61.27%-29.45M | -53.65%-25.34M | -73.37%-25.7M |
| Net non-operating interest income expense | 76.26%25.02M | 58.05%5.88M | 68.57%6.3M | 70.80%6.61M | 117.31%6.23M | 253.26%14.19M | 39.60%3.72M | 389.40%3.74M | 812.74%3.87M | 1,626.51%2.87M |
| Non-operating interest income | 76.26%25.02M | 58.05%5.88M | 68.57%6.3M | 70.80%6.61M | 117.31%6.23M | 253.26%14.19M | 39.60%3.72M | 389.40%3.74M | 812.74%3.87M | 1,626.51%2.87M |
| Other net income (expense) | ||||||||||
| Income before tax | -33.60%-133.81M | -31.58%-39.66M | -32.73%-34.13M | -46.71%-31.5M | -24.90%-28.53M | -48.08%-100.16M | -55.26%-30.14M | -46.95%-25.71M | -33.62%-21.47M | -55.78%-22.84M |
| Income tax | ||||||||||
| Net income | -33.60%-133.81M | -31.58%-39.66M | -32.73%-34.13M | -46.71%-31.5M | -24.90%-28.53M | -48.08%-100.16M | -55.26%-30.14M | -46.95%-25.71M | -33.62%-21.47M | -55.78%-22.84M |
| Net income continuous Operations | -33.60%-133.81M | -31.58%-39.66M | -32.73%-34.13M | -46.71%-31.5M | -24.90%-28.53M | -48.08%-100.16M | -55.26%-30.14M | -46.95%-25.71M | -33.62%-21.47M | -55.78%-22.84M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -33.60%-133.81M | -31.58%-39.66M | -32.73%-34.13M | -46.71%-31.5M | -24.90%-28.53M | -48.08%-100.16M | -55.26%-30.14M | -46.95%-25.71M | -33.62%-21.47M | -55.78%-22.84M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -33.60%-133.81M | -31.58%-39.66M | -32.73%-34.13M | -46.71%-31.5M | -24.90%-28.53M | -48.08%-100.16M | -55.26%-30.14M | -46.95%-25.71M | -33.62%-21.47M | -55.78%-22.84M |
| Basic earnings per share | 7.64%-1.45 | 10.64%-0.42 | 12.20%-0.36 | 0.94%-0.3368 | 8.33%-0.33 | -24.60%-1.57 | -56.67%-0.47 | -20.59%-0.41 | -6.25%-0.34 | -20.00%-0.36 |
| Diluted earnings per share | 7.64%-1.45 | 10.64%-0.42 | 12.20%-0.36 | 0.94%-0.3368 | 8.33%-0.33 | -24.60%-1.57 | -56.67%-0.47 | -20.59%-0.41 | -6.25%-0.34 | -20.00%-0.36 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |